Geoffrey Lawrence is research director at Reason Foundation.
-
Model legislation for optimal state regulation of hemp cannabinoids
Reason Foundation’s model legislation offers a clear and practical framework for states seeking to regulate adult-use hemp cannabinoids effectively.
-
Psychedelic treatment for neurodegenerative disorders
Recent research suggests that psychedelics, such as psilocybin and LSD, show strong potential as effective treatments for neurodegenerative disorders.
-
Debt and liquidity in America’s 10 largest cities
During fiscal year 2022, nine of America’s 10 most populous cities generated enough revenue to finance their expenditures.
-
Batch-tracking: The next wave of marijuana tracking systems
Maine recently implemented a first-of-its-kind system to track marijuana sales, setting a new standard for the industry.
-
A single cannabis retailer license type would benefit both marijuana and hemp businesses
If the tax and regulatory structure for state-licensed marijuana weren’t so restrictive, a market for hemp-derived products might never have emerged.
-
How the FDA can safely approve a promising but controversial mental health drug
The FDA’s existing processes may be able to address the advisory committee’s worries about the previous tests.
-
Marijuana rescheduling is good news, but California still needs to reduce state taxes and regulations
California lawmakers need to do their part by reducing taxes and unnecessary regulations on legal cannabis products.
-
California should legalize psychedelics and learn from its marijuana regulation mistakes
The state’s high cannabis taxes and burdensome regulations make legal marijuana products expensive and keep the illicit market thriving.
-
Ibogaine treatment for opioid use disorder
Policymakers should consider ibogaine as a potential alternative treatment for opioid use disorder.
-
Florida’s attorney general challenges marijuana initiative with spurious arguments
Florida voters have the chance to vote on a marijuana ballot initiative, but Florida politicians are trying to keep that from happening.
-
Survey shows stereotype of the lazy, lefty marijuana smoker doesn’t reflect reality
Marijuana users come from all different backgrounds and are not restricted to a particular political affiliation, education level, income bracket, career position, or location.
-
A policy framework for personal psychedelics licenses
Psychedelic licenses for consumers have advantages over the current approach in two U.S. states that rely on professionals to dispense and facilitate services.
-
The Breakthrough Therapies Act could spur research and improve access to life-saving drugs
The Breakthrough Therapies Act would pave the way for more accessible and innovative mental health treatments while also enabling state-level adaptation.
-
Marijuana social equity programs should be redesigned to focus on restorative justice
Social equity should not simply be a false mantra for politically connected and well-capitalized opportunists to distort new marijuana markets or exploit the public purse.
-
New study of psychedelic ibogaine could motivate policy reforms
A recent study could help remove barriers to the development of ibogaine as a promising treatment for opioid addiction.
-
Wisconsin Republicans propose state marijuana monopoly
Wisconsin Republicans appear set to propose one of the most restrictive medical marijuana programs in the nation.
-
Drug prohibition has failed, it is time to legalize drugs
A legal and regulated market for drugs—even hard drugs—could better address the underlying concerns of every relevant party in the drug debate.
-
California law would create arbitrary and questionable bans for cannabis product labels
The bill passed by the state legislature and headed to Gov. Gavin Newsom would add to California's overregulation of legal marijuana products without resolving any problems.